Literature DB >> 25253502

Assessing in vivo toxicity of graphene materials: current methods and future outlook.

Yufei Ma1, He Shen, Xiaolong Tu, Zhijun Zhang.   

Abstract

Graphene, a novel 2D carbon nanomaterial with unique properties, has attracted massive attention. Evaluating its toxicity is of great significance due to its potential applications in many fields, especially in biomedicine. In this review, the toxicity of graphene-based nanomaterials (GNMs) and related mechanisms at the molecular and cellular level, various approaches to evaluation of the in vivo toxicity of GNMs and major factors defining their toxicity will be discussed and summarized. This review will allow better understanding of the in vitro and in vivo toxicity of GNMs, which, we believe, may facilitate design and fabrication of novel, biocompatible and efficient GNM-based systems for biomedical applications.

Entities:  

Keywords:  biomedicine; graphene; graphene oxide; in vivo; toxicity

Mesh:

Substances:

Year:  2014        PMID: 25253502     DOI: 10.2217/nnm.14.68

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  13 in total

Review 1.  Toxicology of graphene-based nanomaterials.

Authors:  Gaurav Lalwani; Michael D'Agati; Amit Mahmud Khan; Balaji Sitharaman
Journal:  Adv Drug Deliv Rev       Date:  2016-05-03       Impact factor: 15.470

2.  Endotoxin-Free Preparation of Graphene Oxide and Graphene-Based Materials for Biological Applications.

Authors:  Dorsa Parviz; Michael Strano
Journal:  Curr Protoc Chem Biol       Date:  2018-10-04

Review 3.  Graphene-based platforms for cancer therapeutics.

Authors:  Sunny C Patel; Stephen Lee; Gaurav Lalwani; Cassandra Suhrland; Sayan Mullick Chowdhury; Balaji Sitharaman
Journal:  Ther Deliv       Date:  2016-01-15

4.  Graphene Oxide Dysregulates Neuroligin/NLG-1-Mediated Molecular Signaling in Interneurons in Caenorhabditis elegans.

Authors:  He Chen; Huirong Li; Dayong Wang
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

Review 5.  Trigger-Responsive Gene Transporters for Anticancer Therapy.

Authors:  Santhosh Kalash Rajendrakumar; Saji Uthaman; Chong Su Cho; In-Kyu Park
Journal:  Nanomaterials (Basel)       Date:  2017-05-26       Impact factor: 5.076

6.  In vivo toxicological evaluation of graphene oxide nanoplatelets for clinical application.

Authors:  Mohammad Amrollahi-Sharifabadi; Mohammad Kazem Koohi; Ehsan Zayerzadeh; Mohammad Hassan Hablolvarid; Jalal Hassan; Alexander M Seifalian
Journal:  Int J Nanomedicine       Date:  2018-08-22

7.  Metabolomic insights of macrophage responses to graphene nanoplatelets: Role of scavenger receptor CD36.

Authors:  Sherleen Xue-Fu Adamson; Ruoxing Wang; Wenzhuo Wu; Bruce Cooper; Jonathan Shannahan
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

8.  Biocompatible synthesis of reduced graphene oxide from Euphorbia heterophylla (L.) and their in-vitro cytotoxicity against human cancer cell lines.

Authors:  K Lingaraju; H Raja Naika; G Nagaraju; H Nagabhushana
Journal:  Biotechnol Rep (Amst)       Date:  2019-09-12

Review 9.  Graphene: The Missing Piece for Cancer Diagnosis?

Authors:  Sandra M A Cruz; André F Girão; Gil Gonçalves; Paula A A P Marques
Journal:  Sensors (Basel)       Date:  2016-01-21       Impact factor: 3.576

10.  Reduced graphene oxide: nanotoxicological profile in rats.

Authors:  Monique Culturato Padilha Mendonça; Edilene Siqueira Soares; Marcelo Bispo de Jesus; Helder José Ceragioli; Silvia Pierre Irazusta; Ângela Giovana Batista; Marco Aurélio Ramirez Vinolo; Mário Roberto Maróstica Júnior; Maria Alice da Cruz-Höfling
Journal:  J Nanobiotechnology       Date:  2016-06-24       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.